Modular Content
in Life Sciences

The MLR (Medical, Legal, Regulatory) review process is the most significant structural constraint on commercial content velocity in pharmaceutical organisations. It is also the most misunderstood — because it is frequently treated as a process problem when it is, in fact, an architecture problem.

The process critique goes: MLR takes too long, reviewers are too cautious, the committee is too large, the revision cycles are too many. These observations are often accurate. But they are not the root cause. The root cause is that the unit of MLR review is wrong. Pharmaceutical organisations submit finished assets to MLR — eDetails, leave-behinds, email campaigns, patient education booklets — and ask reviewers to assess the entirety of each asset as a single review unit. The asset contains 8–15 distinct claims, each requiring individual validation. Cross-claim interactions must be assessed. Channel-specific regulatory requirements must be verified for each market. Format compliance must be confirmed.

At this level of complexity per review unit, a 6–14 week cycle time is not a process inefficiency. It is a rational response to the review burden being placed on the committee. Making the process faster without changing the architecture just increases reviewer error rate. The answer is to change what is being reviewed.

The modular content architecture changes the review unit from a finished asset to a discrete component — a single claim or claim cluster, typically 250–800 words, with a defined scope, a defined evidence base, and a defined set of approved uses. The reviewer assesses one claim, one evidence link, and one set of deployment conditions. The review complexity falls by 70–85%. The cycle time follows.

Once approved, the component is a permanent commercial asset. It can be deployed in any channel, market, or format for which it has received approval, without re-review. The assembly of components into finished assets is a selection and sequencing activity — not a new production cycle, and not a new review cycle.

Modular content is a structured library of pre-approved, claim-specific content components from which compliant promotional and medical education materials are assembled. The definition has four operative terms, each of which is architecturally significant.

Structured library — not a folder of approved content, but a tagged, searchable, version-controlled repository in which each component has defined metadata: claim type, audience, funnel stage, channel compatibility, market approval status, expiry date, and linked evidence base. An unstructured collection of approved content is not a modular architecture. It is a filing system.

Pre-approved — MLR review has occurred at the component level, before assembly into a finished asset. This is the inversion of the traditional review sequence and is the structural source of the cycle time reduction. Assembly-level review (confirming that selected components are being used within their approved scope) is typically 10–15% of the duration of a full asset review.

Claim-specific — each component addresses one specific claim or claim cluster. A mechanism of action component describes the mechanism. An efficacy summary component presents efficacy data from a specified study. They are not combined until assembly. This specificity is what makes reuse possible: a mechanism component approved for Market A can be deployed in Market B if the regulatory approval covers it, without rebuilding the mechanism content for B's context.

Assembled — finished assets are constructed by selecting components from the library and sequencing them for the specific channel, audience, and market. Assembly is guided by a defined playbook that specifies which components are required for each asset type, which are optional, and which are excluded for specific markets or audiences.

A complete BCB modular content architecture for a pharmaceutical product contains 38–60 components organised into six functional categories. The taxonomy is designed to cover the full commercial and medical education content requirement across all audience types and funnel stages, with no gaps that would require an out-of-library production cycle.

Supporting component categories

Beyond the six core categories, a complete BCB modular architecture includes supporting components for three additional functions. Peer and advocacy components — KOL endorsement summaries, congress presentation abstracts, case report frameworks — serve the Advocate stage of the HCP funnel and the Knowledge Seeker and Relationship Seeker archetypes specifically. Patient-facing components — disease management guides, treatment expectation frameworks, adherence support content, side-effect management guides — serve the patient track and require separate regulatory pathway planning (DTC/DTP compliance by market). Formulary and institutional components — value dossier sections, budget impact summaries, risk management plan summaries — serve the Institutional Gatekeeper audience and operate on a distinct regulatory and governance track from promotional components.

Building a modular component library is not a content production project. It is an architectural design project that happens to produce content. The sequence matters: the architectural decisions made before the first component is written determine how reusable, scalable, and MLR-efficient the library will be.

Step 01 — Claim mapping

Before writing components, map the complete claim universe for the product — every approved claim, every study that supports each claim, every market-specific regulatory constraint on each claim's use. This mapping is the single source of truth for the component library. A component that is written without its claim map is not a modular component — it is a content fragment with no governance architecture.

The claim map also identifies claim interdependencies — claims that can only be made in combination with other claims, claims that are mutually exclusive by market, and claims that require specific safety context to be used compliantly. These interdependencies become the assembly rules that govern how components can be combined.

Step 02 — Component specification

Each component is specified before it is written: claim scope (precisely what this component claims and does not claim), evidence base (which studies support each specific claim within the component), audience(s), funnel stage(s), channel formats, market applicability, required safety context (which safety components must accompany this component in any assembled asset), and expiry conditions (new data, label change, regulatory update).

The specification document is submitted to the MLR committee before the component is written — allowing MLR to identify scope, evidence, and compliance issues before production cost is incurred. This is a second-order benefit of modular architecture that most organisations do not initially anticipate: the specification review is faster than a full MLR review and catches the structural issues that account for most revision cycles in asset-based workflows.

Step 03 — Component production and MLR

Components are written to the approved specification. Each component is reviewed by MLR as a standalone unit — typically by a smaller, more focused review group than the full committee required for asset review. Cycle time for component-level MLR is typically 2–3 weeks. The 4.5-week average total cycle in a BCB deployment includes both component review and assembly-level review, compared to 11 weeks for full asset MLR in a rebuild architecture.

Step 04 — Assembly playbook

The assembly playbook defines the rules for constructing finished assets from approved components. Required components by asset type, optional components by audience or market, excluded components by market regulatory constraint, mandatory safety context pairs, and maximum claim density per asset type. The playbook is approved by MLR as a document — which means that assets assembled in strict accordance with the playbook require only a compliance check at assembly level, not a new review cycle.

A modular content architecture requires a governance model that is structurally different from asset-based governance. Four domains require explicit governance design.

The economic argument for modular content architecture is most clearly expressed through reuse rate — the percentage of content deployed in any given period that was assembled from previously approved components rather than produced from scratch. An organisation with a 12% reuse rate is producing 88% of its deployed content as a new production cycle, with full production and MLR cost, every time. An organisation with a 68% reuse rate is paying production cost for 32% of its deployed content — a 65% reduction in the variable cost of commercial content, on a deployment base that may be growing.

The reuse rate improvement trajectory

Reuse rate does not improve linearly from the first modular deployment. In the first 6 months of a modular architecture deployment, reuse is typically 15–25% because the component library is not yet fully built and the assembly playbook is not yet embedded across markets and channels. Between months 6 and 18, reuse typically accelerates to 50–65% as the library reaches critical coverage and local market teams build assembly capability. Beyond 18 months, mature BCB deployments reach 65–80% reuse — and the rate continues to improve as the library is enriched with performance data and AI-optimised component recommendations.

The economic compounding effect is significant: as reuse rate rises, the cost per additional deployment falls. At 68% reuse, deploying a new asset in a new market costs approximately 32% of what it costs at 12% reuse, on a per-asset basis. Across a 14-market franchise deploying 40–60 assets per year, the cumulative cost differential over three years is typically 3–5× the total cost of building the modular architecture.

A BCB modular content architecture is the enabling infrastructure for three distinct AI-driven commercial capabilities. These capabilities are not available in an asset-based content architecture because they require the structured, tagged, claim-specific component library that only a modular architecture provides.

Modular content architecture implementation follows a defined six-stage sequence. Organisations that attempt to implement in parallel or skip stages typically find themselves with an unstructured component collection that does not achieve the MLR efficiency, reuse rate, or AI-readiness benefits of a properly sequenced BCB modular deployment.